Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.

Diabetes Care. 2019 Jan;42(1):93-101. doi: 10.2337/dc18-1369. Epub 2018 Nov 19.

PMID:
30455333
2.

Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.

Hansen CS, Theilade S, Lajer M, Hansen TW, Rossing P.

Diabet Med. 2018 Nov;35(11):1596-1604. doi: 10.1111/dme.13777. Epub 2018 Aug 20.

PMID:
29999549
3.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

4.

Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes.

Zobel EH, Theilade S, von Scholten BJ, Persson F, Tarnow L, Lajer M, Hansen TW, Rossing P.

Diabetes Care. 2017 Mar;40(3):e32-e33. doi: 10.2337/dc16-2428. Epub 2017 Jan 6. No abstract available.

PMID:
28062524
5.

The Genetic Landscape of Renal Complications in Type 1 Diabetes.

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M; The FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD; The DCCT/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP; GENIE Consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH; SUMMIT Consortium.

J Am Soc Nephrol. 2017 Feb;28(2):557-574. doi: 10.1681/ASN.2016020231. Epub 2016 Sep 19.

6.

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes.

Zobel EH, von Scholten BJ, Lajer M, Jorsal A, Tarnow L, Rasmussen LM, Holstein P, Parving HH, Hansen TW, Rossing P.

J Diabetes Complications. 2016 Nov - Dec;30(8):1603-1608. doi: 10.1016/j.jdiacomp.2016.07.008. Epub 2016 Jul 17.

PMID:
27469295
7.

Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.

Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, Alkayyali S, Brøns C, Forsblom C, Jonsson A, Zetterqvist AV, Nitulescu M, McDavitt CR, Dunér P, Stancáková A, Kuusisto J, Ahlqvist E, Lajer M, Tarnow L, Madsbad S, Rossing P, Kieffer TJ, Melander O, Orho-Melander M, Nilsson P, Groop PH, Vaag A, Lindblad B, Gottsäter A, Laakso M, Goncalves I, Groop L, Gomez MF.

Diabetes. 2016 Jan;65(1):239-54. doi: 10.2337/db15-0122. Epub 2015 Sep 22.

8.

Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.

Østergaard JA, Thiel S, Lajer M, Steffensen R, Parving HH, Flyvbjerg A, Rossing P, Tarnow L, Hansen TK.

Diabetes Care. 2015 Oct;38(10):1898-903. doi: 10.2337/dc15-0851. Epub 2015 Jul 15.

PMID:
26180106
9.

Three-phase bone scintigraphy for diagnosis of Charcot neuropathic osteoarthropathy in the diabetic foot - does quantitative data improve diagnostic value?

Fosbøl M, Reving S, Petersen EH, Rossing P, Lajer M, Zerahn B.

Clin Physiol Funct Imaging. 2017 Jan;37(1):30-36. doi: 10.1111/cpf.12264. Epub 2015 Jul 3.

PMID:
26147681
10.

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.

Nexø BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T, Tarnow L, Hansen B, Lorenzen T, Hørslev-Petersen K, Jensen SB, Bahrami S, Lajer M, Schmidt KL, Parving HH, Junker P, Laska MJ.

Immunol Res. 2016 Feb;64(1):55-63. doi: 10.1007/s12026-015-8671-z.

11.

Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.

Swan EJ, Salem RM, Sandholm N, Tarnow L, Rossing P, Lajer M, Groop PH, Maxwell AP, McKnight AJ; GENIE Consortium.

Diabet Med. 2015 Aug;32(8):1104-9. doi: 10.1111/dme.12763. Epub 2015 Apr 13.

12.

SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes.

Germain M, Pezzolesi MG, Sandholm N, McKnight AJ, Susztak K, Lajer M, Forsblom C, Marre M, Parving HH, Rossing P, Toppila I, Skupien J, Roussel R, Ko YA, Ledo N, Folkersen L, Civelek M, Maxwell AP, Tregouet DA, Groop PH, Tarnow L, Hadjadj S.

Diabetologia. 2015 Mar;58(3):543-8. doi: 10.1007/s00125-014-3459-6. Epub 2014 Dec 6.

13.

Urinary alpha- and pi-glutathione s-transferases in adult patients with type 1 diabetes.

von Scholten BJ, Theilade S, Lajer M, Rossing P.

Nephron Extra. 2014 Jul 31;4(2):127-33. doi: 10.1159/000365481. eCollection 2014 May.

14.

Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes.

Theilade S, Lajer M, Hansen TW, Rossing P.

Acta Diabetol. 2014 Dec;51(6):973-80. doi: 10.1007/s00592-014-0651-6. Epub 2014 Oct 2.

PMID:
25274394
15.

Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.

von Scholten BJ, Lajer M, Goetze JP, Persson F, Rossing P.

Diabet Med. 2015 Mar;32(3):343-52. doi: 10.1111/dme.12594. Epub 2014 Oct 15.

PMID:
25251901
16.

Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.

Sambo F, Malovini A, Sandholm N, Stavarachi M, Forsblom C, Mäkinen VP, Harjutsalo V, Lithovius R, Gordin D, Parkkonen M, Saraheimo M, Thorn LM, Tolonen N, Wadén J, He B, Osterholm AM, Tuomilehto J, Lajer M, Salem RM, McKnight AJ; GENIE Consortium, Tarnow L, Panduru NM, Barbarini N, Di Camillo B, Toffolo GM, Tryggvason K, Bellazzi R, Cobelli C; FinnDiane Study Group, Groop PH.

Diabetologia. 2014 Aug;57(8):1611-22. doi: 10.1007/s00125-014-3256-2. Epub 2014 May 29.

PMID:
24871321
17.

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.

Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJ, Gansevoort RT, Rossing P, de Zeeuw D, Roscioni SS.

Diabet Med. 2014 Sep;31(9):1138-47. doi: 10.1111/dme.12447. Epub 2014 Apr 21.

PMID:
24661264
18.

Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.

Sandholm N, Forsblom C, Mäkinen VP, McKnight AJ, Osterholm AM, He B, Harjutsalo V, Lithovius R, Gordin D, Parkkonen M, Saraheimo M, Thorn LM, Tolonen N, Wadén J, Tuomilehto J, Lajer M, Ahlqvist E, Möllsten A, Marcovecchio ML, Cooper J, Dunger D, Paterson AD, Zerbini G, Groop L; SUMMIT Consortium, Tarnow L, Maxwell AP, Tryggvason K, Groop PH; FinnDiane Study Group.

Diabetologia. 2014 Jun;57(6):1143-53. doi: 10.1007/s00125-014-3202-3. Epub 2014 Mar 5.

PMID:
24595857
19.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2.

20.

Can ADAMTS13 lead us to the paradise of personalized medicine?

Rossing P, Lajer M.

Diabetes. 2013 Oct;62(10):3331-2. doi: 10.2337/db13-1055. No abstract available.

21.

24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study.

Theilade S, Lajer M, Hansen TW, Joergensen C, Persson F, Andrésdottir G, Reinhard H, Nielsen SE, Lacy P, Williams B, Rossing P.

Cardiovasc Diabetol. 2013 Aug 27;12:122. doi: 10.1186/1475-2840-12-122.

22.

Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes.

Jorsal A, Petersen EH, Tarnow L, Hess G, Zdunek D, Frystyk J, Flyvbjerg A, Lajer M, Rossing P.

J Diabetes Complications. 2013 Nov-Dec;27(6):604-8. doi: 10.1016/j.jdiacomp.2013.06.008. Epub 2013 Aug 20.

PMID:
23969018
23.

ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes.

Færch LH, Sejling AS, Lajer M, Tarnow L, Thorsteinsson B, Pedersen-Bjergaard U.

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):374-81. doi: 10.1177/1470320313494431. Epub 2013 Jul 5.

PMID:
23833037
24.

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.

Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S.

Acta Diabetol. 2013 Dec;50(6):887-97. doi: 10.1007/s00592-013-0475-9. Epub 2013 May 17.

PMID:
23681557
25.

Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devices.

Theilade S, Hansen TW, Joergensen C, Lajer M, Rossing P.

Blood Press Monit. 2013 Jun;18(3):156-60. doi: 10.1097/MBP.0b013e328360fb19.

PMID:
23546451
26.

Supportive psychodynamic psychotherapy versus treatment as usual for first-episode psychosis: two-year outcome.

Rosenbaum B, Harder S, Knudsen P, Køster A, Lindhardt A, Lajer M, Valbak K, Winther G.

Psychiatry. 2012 Winter;75(4):331-41. doi: 10.1521/psyc.2012.75.4.331.

PMID:
23244011
27.

Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes.

Theilade S, Lajer M, Persson F, Joergensen C, Rossing P.

Diabetes Care. 2013 Mar;36(3):715-21. doi: 10.2337/dc12-0850. Epub 2012 Nov 27.

28.

Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes.

Albrechtsen A, Grarup N, Li Y, Sparsø T, Tian G, Cao H, Jiang T, Kim SY, Korneliussen T, Li Q, Nie C, Wu R, Skotte L, Morris AP, Ladenvall C, Cauchi S, Stančáková A, Andersen G, Astrup A, Banasik K, Bennett AJ, Bolund L, Charpentier G, Chen Y, Dekker JM, Doney AS, Dorkhan M, Forsen T, Frayling TM, Groves CJ, Gui Y, Hallmans G, Hattersley AT, He K, Hitman GA, Holmkvist J, Huang S, Jiang H, Jin X, Justesen JM, Kristiansen K, Kuusisto J, Lajer M, Lantieri O, Li W, Liang H, Liao Q, Liu X, Ma T, Ma X, Manijak MP, Marre M, Mokrosiński J, Morris AD, Mu B, Nielsen AA, Nijpels G, Nilsson P, Palmer CN, Rayner NW, Renström F, Ribel-Madsen R, Robertson N, Rolandsson O, Rossing P, Schwartz TW; D.E.S.I.R. Study Group, Slagboom PE, Sterner M; DIAGRAM Consortium, Tang M, Tarnow L, Tuomi T, van't Riet E, van Leeuwen N, Varga TV, Vestmar MA, Walker M, Wang B, Wang Y, Wu H, Xi F, Yengo L, Yu C, Zhang X, Zhang J, Zhang Q, Zhang W, Zheng H, Zhou Y, Altshuler D, 't Hart LM, Franks PW, Balkau B, Froguel P, McCarthy MI, Laakso M, Groop L, Christensen C, Brandslund I, Lauritzen T, Witte DR, Linneberg A, Jørgensen T, Hansen T, Wang J, Nielsen R, Pedersen O.

Diabetologia. 2013 Feb;56(2):298-310. doi: 10.1007/s00125-012-2756-1. Epub 2012 Nov 19.

29.

Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes.

Alkayyali S, Lajer M, Deshmukh H, Ahlqvist E, Colhoun H, Isomaa B, Rossing P, Groop L, Lyssenko V.

Diabetologia. 2013 Feb;56(2):323-9. doi: 10.1007/s00125-012-2760-5. Epub 2012 Oct 31.

PMID:
23111731
30.

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zürbig P, Bakker SJ, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Lambers Heerspink HJ.

Diabetologia. 2013 Feb;56(2):259-67. doi: 10.1007/s00125-012-2755-2. Epub 2012 Oct 20.

PMID:
23086559
31.

Discrepancy between tonometric ambulatory and cuff-based office blood pressure measurements in patients with type 1 diabetes.

Theilade S, Lajer M, Joergensen C, Persson F, Rossing P.

J Clin Hypertens (Greenwich). 2012 Oct;14(10):686-93. doi: 10.1111/j.1751-7176.2012.00689.x. Epub 2012 Aug 3.

32.

New susceptibility loci associated with kidney disease in type 1 diabetes.

Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM; DCCT/EDIC Research Group, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP.

PLoS Genet. 2012 Sep;8(9):e1002921. doi: 10.1371/journal.pgen.1002921. Epub 2012 Sep 20.

33.

Ambulatory tonometric blood pressure measurements in patients with diabetes.

Theilade S, Joergensen C, Persson F, Lajer M, Rossing P.

Diabetes Technol Ther. 2012 Jun;14(6):453-6. doi: 10.1089/dia.2012.0006. Epub 2012 Apr 23.

PMID:
22524631
34.

Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.

Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.

Diabet Med. 2012 Aug;29(8):990-4. doi: 10.1111/j.1464-5491.2012.03633.x.

PMID:
22414297
35.

Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.

Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.

Diabet Med. 2012 Mar;29(3):337-44. doi: 10.1111/j.1464-5491.2011.03482.x.

PMID:
21988672
36.

Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy.

Reinhard H, Jacobsen PK, Lajer M, Tarnow L, Astrup AS, Kim WY, Pedersen N, Billestrup N, Mandrup-Poulsen T, Parving HH, Rossing P.

Nephron Clin Pract. 2011;118(3):c309-14. doi: 10.1159/000322667. Epub 2011 Jan 21.

PMID:
21252582
37.

Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.

Hansen HG, Overgaard J, Lajer M, Hubalek F, Højrup P, Pedersen L, Tarnow L, Rossing P, Pociot F, McGuire JN.

Proteomics Clin Appl. 2010 Sep;4(8-9):697-705. doi: 10.1002/prca.200900169.

PMID:
21137087
38.

Osteoprotegerin and mortality in type 2 diabetic patients.

Reinhard H, Lajer M, Gall MA, Tarnow L, Parving HH, Rasmussen LM, Rossing P.

Diabetes Care. 2010 Dec;33(12):2561-6. doi: 10.2337/dc10-0858. Epub 2010 Oct 7.

39.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.

Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.

PMID:
20854382
40.

Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.

Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.

Platelets. 2010;21(7):525-32. doi: 10.3109/09537104.2010.500422.

PMID:
20701458
41.

Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes.

Reinhard H, Jacobsen PK, Lajer M, Pedersen N, Billestrup N, Mandrup-Poulsen T, Parving HH, Rossing P.

Diabetologia. 2010 Oct;53(10):2129-33. doi: 10.1007/s00125-010-1843-4. Epub 2010 Jul 6.

PMID:
20607514
42.
43.

Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy.

Overgaard AJ, Hansen HG, Lajer M, Pedersen L, Tarnow L, Rossing P, McGuire JN, Pociot F.

Proteome Sci. 2010 Feb 3;8:4. doi: 10.1186/1477-5956-8-4.

44.

The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.

Möllsten A, Jorsal A, Lajer M, Vionnet N, Tarnow L.

Diabetologia. 2009 Dec;52(12):2590-3. doi: 10.1007/s00125-009-1550-1. Epub 2009 Oct 16.

PMID:
19834686
45.

Telomere length predicts all-cause mortality in patients with type 1 diabetes.

Astrup AS, Tarnow L, Jorsal A, Lajer M, Nzietchueng R, Benetos A, Rossing P, Parving HH.

Diabetologia. 2010 Jan;53(1):45-8. doi: 10.1007/s00125-009-1542-1. Epub 2009 Oct 4.

PMID:
19802713
46.

Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P.

Diabetes Care. 2009 Sep;32(9):1684-8. doi: 10.2337/dc09-0429. Epub 2009 Jun 5.

47.

The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.

Möllsten A, Lajer M, Jorsal A, Tarnow L.

Mol Genet Metab. 2009 May;97(1):80-4. doi: 10.1016/j.ymgme.2009.01.013. Epub 2009 Feb 3.

PMID:
19246226
48.

Gender differences in first episode psychosis.

Køster A, Lajer M, Lindhardt A, Rosenbaum B.

Soc Psychiatry Psychiatr Epidemiol. 2008 Dec;43(12):940-6. doi: 10.1007/s00127-008-0384-3. Epub 2008 Jun 20.

PMID:
18574541
49.

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Frystyk J, Lajer M, Flyvbjerg A, Parving HH, Vionnet N, Rossing P.

Kidney Int. 2008 Sep;74(5):649-54. doi: 10.1038/ki.2008.201. Epub 2008 May 21.

50.

The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Lajer M, Ek J, Hansen T, Pedersen O, Parving HH.

Mol Genet Metab. 2008 Jul;94(3):347-51. doi: 10.1016/j.ymgme.2008.03.014. Epub 2008 May 7.

PMID:
18467141

Supplemental Content

Support Center